Study exposes opportunities for strengthening
<p>More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published December 12<sup>th</sup><strong> </strong>in the open access journal <em>PLOS Medicine </em>by Professor Xiaodong Guan of Peking University, China, and colleagues.</p>
Source: eurekalert.org
